Journal Guide

Cardiology and Therapy is a fully open access, internationally peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). Emphasis is placed on the publication of high-quality practical and clinical research around new and existing therapies in all areas of cardiology, including interventional cardiology. Studies relating to diagnosis, health economics, outcomes research, patient care, management, and education are also encouraged. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, drug reviews, case reports, and short communications. Moving forward from traditional publishing, Cardiology and Therapy offers a range of additional features designed to increase visibility and readership. As such, each paper is accompanied by a bulleted slide summary giving a time-efficient overview of the content to a wider readership. All submissions have the option to include slide sets, video components, animations, and/or interactive case studies.Cardiology and Therapy publishes supplements and special issues (in English or a local language). Material appropriate for supplements/special issues include: sponsored meeting proceedings, roundtable discussions, workshop reports, case series, and collections of articles on the same topic. All articles are subject to peer review, and must adhere to the IJCME and GPP policies on acknowledgments/disclosures. Proposals for supplements are welcomed, and should be addressed to nicola.cartridge@springer.comFor authors: Upon acceptance of your article for publication, you will be required to pay the article open access fee of £175/€200/$260 per printed page. This will enable you to keep the copyright: you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open, access.

American Heart Association members are eligible for a 20% discount on subscription rates.Edited by some of the world's best-known authorities, Cardiology in Review provides readers with critical state-of-the-art reviews of topics that are relevant to current and future cardiovascular medicine and surgery practice. Each issue includes articles by leading international experts in the areas of cardiovascular epidemiology, pathophysiology, diagnostics, prevention, and therapeutics.Indexed in: MEDLINE/PUBMED, EMBASE, SCOPUS, Science Citation Index Expanded, Current Contents/Clinical MedicineWebsite: www.cardiologyinreview.com.

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents. Each issue contains a series of timely in-depth reviews, original research articles and drug clinical trial studies written by leaders in the field covering a range of current topics in Cardiovascular & Hematological medicinal chemistry.

Cardiovascular Diabetology is ready to receive manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome: this includes genetic, experimental, clinical, pharmacological, epidemiological, molecular biology and laboratory research.

Cardiovascular Diabetology - Endocrinology Reports, an official companion journal to Cardiovascular Diabetology, is an open access journal publishing on clinical, translational and basic science aspects of endocrinology. The journal welcomes original research, reviews, commentaries and case reports on diabetes and all types of endocrine disorders including, but not limited to, metabolic syndrome, thyroid disorders, adrenal disorders, pituitary disorders, bone disorders, obesity, reproductive disorders and neuroendocrine disorders.  

The audience includes physicians, researchers, nurses, nutritionists, pharmacists, podiatrists, psychologists, epidemiologists, exercise physiologists and health care researchers. 

Designed to objectively cover the world of cardiovascular pharmacology and therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field. Homing in on the most exciting work being done on new therapeutic agents, heart failure, hypertension and acute myocardial infarction, among others, Cardiovascular Drugs and Therapy is an authoritative source of current and relevant news that is indispensable for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Current Contents and Index Medicus, the regular articles and frequent free supplementary issues equip you with an up-to-date source defined by the need for accurate information on an ever-changing field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of

Cardiovascular Engineering and Technology is a journal publishing the spectrum of basic to translational research in all aspects of cardiovascular physiology and medical treatment. It is the forum for academic and industrial investigators to disseminate research that utilizes engineering principles and methods to advance fundamental knowledge and technological solutions related to the cardiovascular system. Manuscripts spanning from subcellular to systems level topics are invited, including but not limited to implantable medical devices, hemodynamics and tissue biomechanics, functional imaging, surgical devices, electrophysiology, tissue engineering and regenerative medicine, diagnostic instruments, transport and delivery of biologics, and sensors. In addition to manuscripts describing the original publication of research, manuscripts reviewing developments in these topics or their state-of-art are also invited.

Cardiovascular Intervention and Therapeutics (CVIT) is an international journal covering the field of cardiovascular disease and includes cardiac (coronary and noncoronary) and peripheral interventions and therapeutics. Articles are subject to peer review and complete editorial evaluation prior to any decision regarding acceptability. CVIT is an official journal of The Japanese Association of Cardiovascular Intervention and Therapeutics.

Cardiovascular Pathology is a bimonthly journal that presents articles on topics covering the entire spectrum of cardiovascular disease. The Journal's primary objective is to publish papers on disease-oriented morphology and pathogenesis from clinicians and scientists in the cardiovascular field. Subjects covered include cardiovascular biology, prosthetic devices, molecular biology and experimental models of cardiovascular disease.Cardiovascular Pathology also publishes timely and informative reviews on scientific areas in cardiovascular pathology as well as case reports that represent significant or unique observations.For more information about the Society for Cardiovascular Pathology (SCVP), please visit their website at URL: http://scvp.net .Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Cardiovascular Research is the International Basic Science Journal of the European Society of Cardiology. The Journal is concerned with both basic and clinical research in the field of cardiovascular physiology and pathophysiology. The Journal welcomes submission of papers both at the molecular, subcellular, cellular, organ and organism level, and of clinically oriented papers offering insight into (patho)physiological mechanisms. Manuscripts may be submitted as Original Articles, Rapid Communications or Reviews. Moreover, the Journal publishes Letters to the Editor and Editorials (the latter are usually invited).Cardiovascular Research is proud of its fast Reviewing and Editorial Decision system. Manuscripts are normally evaluated by three members from an international panel of reviewers and, in most cases, we provide a first editorial decision within 22 days of receipt.

Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine.Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management; and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, congenital heart disease, coronary heart disease, epidemiology, genetics, health services and outcomes research, invasive imaging, molecular cardiology, preventive cardiology, and vascular medicine.Cardiovascular Revascularization Medicine will consider all articles describing clinical trials and translational research (ie, those that unite the clinic with the laboratory). The Journal publishes original articles, rapid communications, reviews, technical notes, teaching editorials, and special features. Original articles that address any aspect of cardiovascular revascularization medicine are invited. Letters to the Editor and interesting images are encouraged.